Qaytona is free while it's in beta — Get started

Ingredients

Panax Notoginseng

Panax notoginseng · Sanqi · Tienchi ginseng

Snapshot

IndicationsContraindications
  • Ischemic stroke recovery1
  • Unstable angina (IV injection)2
  • Acute myocardial infarction adjunct3
  • Platelet inhibition with aspirin4, 5
  • Pregnancy or breastfeeding6
  • Before surgery7

Panax notoginseng (sanqi, tienchi ginseng) is a root used in traditional Chinese medicine, with saponins as its principal active components8. It acts largely through antiplatelet, anti-inflammatory, and microcirculatory effects9. Supplementation follows from that vascular effect: recovery after ischemic stroke, angina, and adjunctive care after myocardial infarction. The typical patient has established ischemic cardiovascular or cerebrovascular disease and is already on standard therapy.

In a 2023 randomized trial of a saponin capsule after ischemic stroke, more patients reached functional independence than on placebo. A meta-analysis of randomized trials agreed but rated the certainty of evidence moderate to very low10. In acute myocardial infarction, a meta-analysis found fewer major adverse cardiac events with the saponin injection added to usual care3. In mouse models of ischemic stroke, a 2026 study of a combined Salvia miltiorrhiza and Panax notoginseng extract reduced infarct volume and sustained collateral perfusion; no human trial has tested it. Many products list notoginseng, mostly capsules and liquids; see Form comparison.

The antiplatelet action is the reason for the most consequential caution: added to aspirin, saponins further inhibited platelet aggregation in a small randomized trial. Health Canada labels ask for a practitioner's advice before use with prescription medications6. Health Canada also labels against use in pregnancy and breastfeeding6.

Last updated October 16, 2026. Read how we make monographs.

In the full monograph

46 sources, 46 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Efficacy and Safety of Panax notoginseng Saponins in the Treatment of Adults With Ischemic Stroke in China: A Randomized Clinical Trial.pubmed.ncbi.nlm.nih.govWu, Song, Zhang et al. · JAMA network open · 2023 · Pubmed
  2. 2Efficacy of Xueshuantong Injection in Reducing Residual Inflammatory Risk in Unstable Angina Patients: A Randomized Double-Blind Controlled Trial.pubmed.ncbi.nlm.nih.govWang, Lyu, Lu et al. · Chinese journal of integrative medicine · 2026 · Pubmed
  3. 3Efficacy and safety of Panax notoginseng saponin injection in the treatment of acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.pubmed.ncbi.nlm.nih.govChen, Gao, Guo et al. · Frontiers in pharmacology · 2024 · Pubmed
  4. 4Panax notoginseng preparation plus aspirin versus aspirin alone on platelet aggregation and coagulation in patients with coronary heart disease or ischemic stroke: A meta-analysis of randomized controlled trials.pubmed.ncbi.nlm.nih.govDai, Zhang, Jiang et al. · Frontiers in pharmacology · 2022 · Pubmed
  5. 5Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism.pubmed.ncbi.nlm.nih.govWang, Yang, Song et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021 · Pubmed
  6. 6Health Canadahealth-products.canada.caLabel statements and adult daily amounts Health Canada authorized on licensed natural health products with this ingredient alone, from the Licensed Natural Health Products Database. Contains information licensed under the Open Government Licence – Canada
  7. 7US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
  8. 8Panax notoginseng saponins against ischemic stroke: From molecule to clinic.pubmed.ncbi.nlm.nih.govZeng, Zhao, Nie et al. · Journal of ethnopharmacology · 2026 · Pubmed
  9. 9Latest Evidence and Perspectives of Panax Notoginseng Extracts and Preparations for the Treatment of Cardiovascular Diseases.pubmed.ncbi.nlm.nih.govZhao, Fu, Wang et al. · Journal of cardiovascular pharmacology · 2025 · Pubmed
  10. 10Efficacy and safety of Panax notoginseng saponins (Xuesaitong) for patients with acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials.pubmed.ncbi.nlm.nih.govShi, Feng, Li et al. · Frontiers in pharmacology · 2023 · Pubmed